Literature DB >> 24969358

The endourological treatment of renal matrix stones.

Paolo Beltrami1, Lorenzo Ruggera, Andrea Guttilla, Alessandro Iannetti, Fabio Zattoni, Francesca Gigli, Patrizia Bernich, Filiberto Zattoni.   

Abstract

OBJECTIVE: To report our experience with the endourological treatment of renal matrix stones, an infrequent form of urinary calculi whose diagnosis and treatment are often difficult.
METHODS: From 1990 to 2010 we treated 9 female patients with matrix calculi using the endourological approach; 4 presented with renal colics, 3 with symptomatic urinary tract infection and 2 with asymptomatic bacteriuria. Six patients underwent percutaneous lithotripsy and 3 retrograde intrarenal surgery as first-line therapy. Three cases needed a multidisciplinary approach.
RESULTS: The six percutaneous procedures were successful after a single session, while the retrograde approach required multiple treatments; a single case needed a shock wave session to complete the fragmentation, in another one a percutaneous lithotripsy was necessary after the first procedure, and a third case needed multidisciplinary treatment.
CONCLUSIONS: Percutaneous lithotripsy has been confirmed as the first option for matrix stones. The retrograde approach - by confirming the suspected diagnosis and being minimally invasive - may be employed to treat either lower-size stones or stones at high risk of recurrence.

Entities:  

Mesh:

Year:  2014        PMID: 24969358     DOI: 10.1159/000357624

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  New techniques on uropaleopathology.

Authors:  Maximillien Gilles Baron; Nadia Benmoussa; Dominique Bazin; Isabelle Abadie; Michel Daudon; Philippe Charlier
Journal:  Urolithiasis       Date:  2018-06-05       Impact factor: 3.436

2.  Matrix Stone Occupying an Entire Renal Collecting System: A Case Report and Video of Diagnostic Ureterorenoscopy.

Authors:  Jonathan Cobley; Yih Chyn Phan; Wasim Mahmalji
Journal:  Case Rep Urol       Date:  2018-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.